Back to search
🇫🇷

France · FR · FR:66666597

DILTIAZEM ZENTIVA LAB LP 200 mg, gélule à libération prolongée

ReimbursedATC C05AE03

Last synced from Base de données publique des médicaments — BDPM (France) on

Identification

ManufacturerZENTIVA FRANCE
CountryFR (France)
ATC codeC05AE03
Dispensing
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026

Packs · 2

  • cip13
    3400926943660
    plaquette(s) PVC-Aluminium de 28 gélule(s)
    EUR 4.95
  • cip13
    3400926943950
    plaquette(s) PVC-Aluminium de 84 gélule(s)
    EUR 14.72

Annotations

No annotations yet.

Raw payload (JSON)
{
  "cis": "66666597",
  "date_amm": "2013-04-10",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule à libération prolongée",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

Related drugs

Other records sharing ATC code C05AE03.

Access this data programmatically

Query DILTIAZEM ZENTIVA LAB LP 200 mg, gélule à libération prolongée and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.